April 4, 2017
FDA OK’s Teva’s Huntington’s disease drug
U.S. Food and Drug Administration (FDA) has approved Teva’s Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD).
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Huntington’s disease (HD)